e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Lung infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ANCA (antineutrophil cytoplasmic autoantibody) in the chronic lower respiratory tract infection
S. Ohno, N. Saku, Y. Sugiyama (Kawachi/Minamikawachi, Japan)
Source:
Annual Congress 2002 - Lung infections
Session:
Lung infections
Session type:
Thematic Poster Session
Number:
2817
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ohno, N. Saku, Y. Sugiyama (Kawachi/Minamikawachi, Japan). ANCA (antineutrophil cytoplasmic autoantibody) in the chronic lower respiratory tract infection. Eur Respir J 2002; 20: Suppl. 38, 2817
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Excerpts from the upcoming ERS Monograph on COVID-19
Related content which might interest you:
Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF)
Source: Eur Respir J 2007; 30: Suppl. 51, 648s
Year: 2007
Antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in cystic fibrosis (CF)
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004
Antineutrophil cytoplasmic antibody (ANCA) associated lung-renal vasculitides: A single centre perspective
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Anti-neutrophil cytoplasmic antibodies and immune complexes vasculitis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=91
Year: 2005
Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis
Source: Eur Respir J 2009; 34: 1079-1085
Year: 2009
The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis
Source: Eur Respir J 2011; 37: 1503-1513
Year: 2011
Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection?
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005
Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Year: 2018
Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 308s
Year: 2006
The role of IgA in recurrent respiratory infections (RRIs) in children
Source: Eur Respir J 2001; 18: Suppl. 33, 106s
Year: 2001
Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy
Source: Eur Respir J 2015; 46: 554-557
Year: 2015
IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002
Lower concentration of anti-capsular polysaccharide IgG antibodies (AB) in patients with pneumococcal respiratory tract infections (RTI)
Source: Eur Respir J 2003; 22: Suppl. 45, 546s
Year: 2003
Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD)
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Myositis-specific antibodies in a cohort of idiopathic interstitial pneumonias with suggestive morphologies.
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept